IL2 and neoplasm: In a previous study, we determined that in vitro activation of tumor-sensitized L-selectinlow precursors with anti-CD3 mAb and high concentrations of IL-2 (100 U/ml) induced rapid proliferation of CD8+ effector cells [28].